[Federal Register Volume 86, Number 140 (Monday, July 26, 2021)]
[Notices]
[Page 40066]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15865]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of The Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Advisory Committee 
on Research on Women's Health.
    The meeting will be held as a virtual meeting and open to the 
public. Individuals who plan to view the virtual meeting and need 
special assistance or other reasonable accommodations to view the 
meeting, should notify the Contact Person listed below in advance of 
the meeting. The meeting will be videocast and can be accessed from the 
NIH Videocasting and Podcasting website (http://videocast.nih.gov/).

    Name of Committee: Advisory Committee on Research on Women's 
Health.
    Date: September 1, 2021.
    Time: 1:30 p.m. to 2:30 p.m.
    Agenda: Presentation from the ACRWH Working Group on the Women's 
Health Consensus Conference.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Samia Noursi, Ph.D., Associate Director, Science 
Policy, Planning, and Analysis, Office of Research on Women's 
Health, National Institutes of Health, 6707 Democracy Blvd., Room 
402, Bethesda, MD 20892, 301-496-9472, <a href="/cdn-cgi/l/email-protection#c7b4a6aaaea6e9a9a8b2b5b4ae87a9aeafe9a0a8b1"><span class="__cf_email__" data-cfemail="3043515d59511e5e5f45424359705e59581e575f46">[email protected]</span></a>.

    Name of Committee: Advisory Committee on Research on Women's 
Health.
    Date: October 20, 2021.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: Reports on Congressionally Recommended Women's Health 
Priorities: Rising Maternal Morbidity and Mortality Rates; Rising 
Rates of Chronic Debilitating Conditions in Women; and Stagnant 
Cervical Cancer Survival Rates.
    Date: October 21, 2021.
    Time: 9:30 a.m. to 4:30 p.m.
    Agenda: Director's Report, NCI Director Presentation, Women's 
Health Consensus Conference Working Group Report, and concept 
clearances for various ORWH programs.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Samia Noursi, Ph.D., Associate Director, Science 
Policy, Planning, and Analysis, Office of Research on Women's 
Health, National Institutes of Health, 6707 Democracy Blvd., Room 
402, Bethesda, MD 20892, 301-496-9472, <a href="/cdn-cgi/l/email-protection#0774666a6e662969687275746e47696e6f29606871"><span class="__cf_email__" data-cfemail="0370626e6a622d6d6c7671706a436d6a6b2d646c75">[email protected]</span></a>.

    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meetings. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https://orwh.od.nih.gov/, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: July 21, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-15865 Filed 7-23-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>